APA
Fagerholm R., Khan S., Schmidt M. K., García-Closas M., Heikkilä P., Saarela J., Beesley J., Jamshidi M., Aittomäki K., Liu J., Ali H. R., Andrulis I. L., Beckmann M. W., Behrens S., Blows F. M., Brenner H., Chang-Claude J., Couch F. J., Czene K., Fasching P. A., Figueroa J., Floris G., Glendon G., Guo Q., Hall P., Hallberg E., Hamann U., Holleczek B., Hooning M. J., Hopper J. L., Jager A., Kabisch M., Keeman R., Kosma V., Lambrechts D., Lindblom A., Mannermaa A., Margolin S., Provenzano E., Shah M., Southey M. C., Dennis J., Lush M., Michailidou K., Wang Q., Bolla M. K., Dunning A. M., Easton D. F., Pharoah P. D. P., Chenevix-Trench G., Blomqvist C. & Nevanlinna H. (20170929). TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. : Oncotarget.
Chicago
Fagerholm Rainer, Khan Sofia, Schmidt Marjanka K, García-Closas Montserrat, Heikkilä Päivi, Saarela Jani, Beesley Jonathan, Jamshidi Maral, Aittomäki Kristiina, Liu Jianjun, Ali H Raza, Andrulis Irene L, Beckmann Matthias W, Behrens Sabine, Blows Fiona M, Brenner Hermann, Chang-Claude Jenny, Couch Fergus J, Czene Kamila, Fasching Peter A, Figueroa Jonine, Floris Giuseppe, Glendon Gord, Guo Qi, Hall Per, Hallberg Emily, Hamann Ute, Holleczek Bernd, Hooning Maartje J, Hopper John L, Jager Agnes, Kabisch Maria, Keeman Renske, Kosma Veli-Matti, Lambrechts Diether, Lindblom Annika, Mannermaa Arto, Margolin Sara, Provenzano Elena, Shah Mitul, Southey Melissa C, Dennis Joe, Lush Michael, Michailidou Kyriaki, Wang Qin, Bolla Manjeet K, Dunning Alison M, Easton Douglas F, Pharoah Paul D P, Chenevix-Trench Georgia, Blomqvist Carl and Nevanlinna Heli. 20170929. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. : Oncotarget.
Harvard
Fagerholm R., Khan S., Schmidt M. K., García-Closas M., Heikkilä P., Saarela J., Beesley J., Jamshidi M., Aittomäki K., Liu J., Ali H. R., Andrulis I. L., Beckmann M. W., Behrens S., Blows F. M., Brenner H., Chang-Claude J., Couch F. J., Czene K., Fasching P. A., Figueroa J., Floris G., Glendon G., Guo Q., Hall P., Hallberg E., Hamann U., Holleczek B., Hooning M. J., Hopper J. L., Jager A., Kabisch M., Keeman R., Kosma V., Lambrechts D., Lindblom A., Mannermaa A., Margolin S., Provenzano E., Shah M., Southey M. C., Dennis J., Lush M., Michailidou K., Wang Q., Bolla M. K., Dunning A. M., Easton D. F., Pharoah P. D. P., Chenevix-Trench G., Blomqvist C. and Nevanlinna H. (20170929). TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. : Oncotarget.
MLA
Fagerholm Rainer, Khan Sofia, Schmidt Marjanka K, García-Closas Montserrat, Heikkilä Päivi, Saarela Jani, Beesley Jonathan, Jamshidi Maral, Aittomäki Kristiina, Liu Jianjun, Ali H Raza, Andrulis Irene L, Beckmann Matthias W, Behrens Sabine, Blows Fiona M, Brenner Hermann, Chang-Claude Jenny, Couch Fergus J, Czene Kamila, Fasching Peter A, Figueroa Jonine, Floris Giuseppe, Glendon Gord, Guo Qi, Hall Per, Hallberg Emily, Hamann Ute, Holleczek Bernd, Hooning Maartje J, Hopper John L, Jager Agnes, Kabisch Maria, Keeman Renske, Kosma Veli-Matti, Lambrechts Diether, Lindblom Annika, Mannermaa Arto, Margolin Sara, Provenzano Elena, Shah Mitul, Southey Melissa C, Dennis Joe, Lush Michael, Michailidou Kyriaki, Wang Qin, Bolla Manjeet K, Dunning Alison M, Easton Douglas F, Pharoah Paul D P, Chenevix-Trench Georgia, Blomqvist Carl and Nevanlinna Heli. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. : Oncotarget. 20170929.